The association of placental histopathological lesions and adverse obstetric outcomes in patients with Müllerian anomalies.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
05 2022
Historique:
received: 27 12 2021
revised: 04 03 2022
accepted: 22 03 2022
pubmed: 9 4 2022
medline: 25 5 2022
entrez: 8 4 2022
Statut: ppublish

Résumé

An increased risk of an unfavorable obstetric outcome has been reported in relation with Müllerian anomalies (MA). We evaluated whether placental lesions are more frequent among patients with MA and correlates with adverse pregnancy outcomes. The medical records and placental histopathologyy of consecutive patients with MA between 2007 and 2020 were reviewed. A control group matched for maternal age and pregnancy complications was selected in a 1:1 ratio. Characteristics were then compared between the MA and control groups. The study group included 110 patients with MA. Patients in the MA group gave birth at earlier gestational age as (35.8 ± 3.3 vs 39.1 ± 1.3 weeks, respectively, P < 0.001). Placental weight <10th percentile was significantly more frequent in the MA cohort compared with controls (31% vs. 6%, respectively, p < 0.001). Higher rates of vascular and villous lesions of maternal vascular malperfusion (MVM) were also detected in the MA group (P = 0.04, P = 0.01, respectively). On multivariable analysis the presence of MA was an independent predictor of composite placental MVM lesions (OR 3.9, 95% CI 2.2, 6, p = 0.04). Using multivariate logistic regression models, the presence of MA was also found to be an independent predictor of small for gestational age (SGA), (OR 4.2, 95% CI 2.7, 11.7, p = 0.01). MA are associated with placental MVM lesions and SGA independent of background confounders including gestational age - suggesting a placental involvement in the association between MA and adverse pregnancy outcomes. Prospective studies among larger cohorts are needed to corroborate our results.

Identifiants

pubmed: 35395583
pii: S0143-4004(22)00200-4
doi: 10.1016/j.placenta.2022.03.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-28

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Ann Dekalo (A)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel. Electronic address: ann2003s@gmail.com.

Ohad Feldstein (O)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Dorin Tal (D)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Matan Friedman (M)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Letizia Schreiber (L)

Department of Pathology, The Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Giulia Barda (G)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Eran Weiner (E)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Michal Levy (M)

Department of Obstetrics and Gynecology, and the Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 5, Holon, 58100, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH